Could a gentle electric field heal the heart? new study tests Pulsed-Field ablation for persistent AF

NCT ID NCT07675395

First seen Jun 30, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study looks at whether pulsed-field ablation (PFA), a non-thermal technique that uses electric pulses to target faulty heart tissue, can reverse structural changes in the heart caused by persistent atrial fibrillation (AF). Researchers will enroll 30 people with persistent AF and use the FARAPULSE system to isolate the pulmonary veins and modify additional heart tissue. They will measure changes in heart size, function, and scarring using echocardiograms, MRI, and invasive pressure readings before and after the procedure, and track whether participants stay free of AF for up to a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Pulsed-field ablation using the FARAPULSE system (FARAWAVE catheter)
What this could lead to
If successful, this could show that pulsed-field ablation not only treats atrial fibrillation but also helps reverse structural damage to the heart, potentially improving long-term outcomes.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply to everyone. The procedure carries risks like bleeding, heart damage, or recurrence of abnormal heart rhythms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taipei Veterans General Hospital

    Taipei, 112, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.